Skip to main content
Livermore
Livermore
ZHEN

BridgeBio Pharma, Inc.

BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001743881

In the last 90 days, BridgeBio Pharma, Inc. insiders filed 0 open-market purchases and 5 sales; 475 institutions reported holding it in 13F filings for Q2 2026, worth $14.4B in total; Viking Global Investors is the only superinvestor holding it.

Superinvestors holding BBIO, Q2 2026

1 superinvestor reports holding BridgeBio Pharma, Inc. on Form 13F, worth $741.0M in total. Weight is BridgeBio Pharma, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.

See all superinvestors
Superinvestors holding BBIO in Q2 2026
Superinvestor% of portfolioSharesValuevs. previous quarter
Viking Global InvestorsAndreas Halvorsen2.1%9,949,219$741.0MReduced−16.0%

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of BBIO each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2026

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−16.0%)

  2. Q1 2026

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−17.7%)

  3. Q4 2025

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−9.9%)

  4. Q3 2025

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−13.9%)

  5. Q2 2025

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−15.9%)
    Sold out
    Duquesne Family Office

  6. Q1 2025

    2 superinvestors holding at quarter end

    New
    Duquesne Family Office
    Reduced
    Viking Global Investors (−12.2%)
    Sold out
    HHLR Advisors (Hillhouse)

  7. Q3 2024

    2 superinvestors holding at quarter end

    Reduced
    HHLR Advisors (Hillhouse) (−26.4%)

  8. Q2 2024

    2 superinvestors holding at quarter end

    Added
    HHLR Advisors (Hillhouse) (+1.7%)

  9. Q1 2024

    2 superinvestors holding at quarter end

    Reduced
    HHLR Advisors (Hillhouse) (−1.7%)

  10. Q4 2023

    2 superinvestors holding at quarter end

    Reduced
    HHLR Advisors (Hillhouse) (−50.0%)

  11. Q3 2023

    2 superinvestors holding at quarter end

    Reduced
    Viking Global Investors (−5.6%), HHLR Advisors (Hillhouse) (−7.0%)

  12. Q2 2023

    2 superinvestors holding at quarter end

    Reduced
    HHLR Advisors (Hillhouse) (−24.8%)

  13. Q1 2023

    2 superinvestors holding at quarter end

    Reduced
    HHLR Advisors (Hillhouse) (−23.3%)

  14. Q4 2022

    2 superinvestors holding at quarter end

    Reduced
    HHLR Advisors (Hillhouse) (−3.3%)